Weihong Zhang

Shuguang, 201900, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

p97-mediated proteostasis is a checkpoint for late-stage thymocyte positive selection.

p97-mediated proteostasis is a checkpoint for late-stage thymocyte positive selection.

Journal: Cellular & molecular immunology

Published: November 25, 2025

Gastric Cancer: Pathobiology and Therapeutics.

Gastric Cancer: Pathobiology and Therapeutics.

Journal: MedComm

Published: July 24, 2025

DNA damage caused by chemotherapy has duality, and traditional Chinese medicine may be a better choice to reduce its toxicity.

DNA damage caused by chemotherapy has duality, and traditional Chinese medicine may be a better choice to reduce its toxicity.

Journal: Frontiers in pharmacology

Published: August 19, 2024

Modeling human gastric cancers in immunocompetent mice.

Modeling human gastric cancers in immunocompetent mice.

Journal: Cancer biology & medicine

Published: June 28, 2024

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Journal: Frontiers in pharmacology

Published: May 30, 2024

Targeting p97-Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity.

Targeting p97-Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity.

Journal: Nature immunology

Published: August 14, 2023

GPNMB+ Gal-3+ hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis.

GPNMB+ Gal-3+ hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis.

Journal: The EMBO journal

Published: March 20, 2023

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.

Journal: Nature communications

Published: January 06, 2023

An engineered xCas12i with high activity, high specificity, and broad PAM range.

An engineered xCas12i with high activity, high specificity, and broad PAM range.

Journal: Protein & cell

Published: October 19, 2022

A YAP/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancer.

A YAP/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancer.

Journal: Protein & cell

Published: May 22, 2022

Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy.

Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy.

Journal: American journal of translational research

Published: September 11, 2020

β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis.

β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis.

Journal: Bioscience reports

Published: March 13, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026